Brno, Czechia

Vitezslav Bryja

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 6.9

ph-index = 1


Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Vitezslav Bryja: Innovator in Cancer Treatment

Introduction

Vitezslav Bryja is a notable inventor based in Brno, Czech Republic. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a focus on leukemia, lymphomas, and solid tumors, his work aims to improve diagnosis and treatment options for patients.

Latest Patents

Vitezslav Bryja holds 2 patents that showcase his expertise in medical research. His latest patents include:

1. **4-(1H-imidazol-5-yl)-1H-pyrrolo[2,3-b]pyridines for use in the treatment of leukaemias, lymphomas and solid tumors** - This patent describes novel compounds that are useful in treating various forms of cancer.

2. **Method of determination of diagnosis and prognosis in patients with B-cell chronic lymphocytic leukemia and oligonucleotides for use in this method** - This invention provides a method for diagnosing and predicting the prognosis of B-cell chronic lymphocytic leukemia by analyzing the Wnt/PCP signaling pathway in biological samples.

Career Highlights

Vitezslav Bryja is affiliated with Masaryk University, where he conducts his research and develops his innovative ideas. His work has been instrumental in advancing the understanding of cancer biology and improving therapeutic strategies.

Collaborations

He collaborates with talented colleagues such as Pavlina Janovska and Michaela Gregorova, who contribute to his research efforts and help in the development of his patented technologies.

Conclusion

Vitezslav Bryja is a prominent figure in the field of cancer research, with a focus on innovative treatments and diagnostic methods. His contributions through patents and collaborations continue to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…